Centro Hospitalar e Universitário de Coimbra (CHUC)

Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article Real-world data in children with achondroplasia after licensing of Vosoritide (2022) Palm K, Bechthold-Dalla Pozza S, Gausche R, Hoegler W, Hoyer-Kuhn H, Huebner A, Keller A, et al. Conference contribution GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE. (2022) Iudici M, Mongin D, Siegert E, Carreira P, Distler J, Henes J, Zanatta E, et al. Conference contribution Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices (2021) Herman A, Uter W, Rustemeyer T, Matura M, Aalto-Korte K, Duus Johansen J, Goncalo M, et al. Journal article A generic curriculum development model for the biomedical physics component of the educational and training programmes of the non-physics healthcare professions (2021) Caruana CJ, Karenauskaite V, Mornstein V, Vano E, Pace E, Lammertsma AA, Maas AJ, et al. Journal article Brain fMRI Predicts Responses to Certolizumab Pegol in RA. an International, Multi-center, Randomized, Double-blind, Placebocontrolled Trial (PreCePRA) (2020) Rech J, Schenker H, Tascilar K, Hagen M, Kleyer A, Simon D, Mendez LV, et al. Conference contribution CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020) Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al. Conference contribution PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020) Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al. Conference contribution